Submitted by Anonymous (not verified) on 19 September 2024 - 13:54
Opinion/decision on a Paediatric investigation plan (PIP): Lenvima, Lenvatinib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Oncology, PIP number: P/0280/2022
Source: